2025-05-14T09:25:03-05:00 2024-06-30 333709623 COHNREZNICK ADVISORY LLC 350 GRANITE STREET SUITE 1200 BRAINTREE MA 02184 990 2023-07-01 043045706 COMMUNITY RESEARCH INITIATIVE OF NEW ENGLAND INC COMM 6175021744 529 MAIN STREET 301 BOSTON MA 02129 JULIE K MARSTON EXECUTIVE DIRECTOR 6175021744 2025-05-13 1 1 JOLANTA TUCK P01340068 7813803520 2025-05-08 2023 2025-03-06 01:10:19Z ACCESSHEALTH MA JULIE K MARSTON 529 MAIN STREET 301 BOSTON MA 02129 25539905 0 X HTTPS://CRIHEALTH.ORG/ X 1989 MA TO PROMOTE THE RAPID STUDY AND APPROVAL OF NEW THERAPIES FOR HIV. 8 7 51 18 0 0 24906452 25355336 153750 184569 0 0 0 0 25060202 25539905 0 0 0 0 4103253 4188748 0 0 174255 20930296 21369548 25033549 25558296 26653 -18391 5441120 5987080 4062722 4627073 1378398 1360007 TO PROMOTE THE RAPID STUDY AND APPROVAL OF NEW THERAPIES FOR HIV; IMPROVE ACCESS TO EXPERIMENTAL TREATMENTS; STUDY NEW WAYS TO KEEP PEOPLE WITH HIV AS HEALTHY AS POSSIBLE; AND TO BRING TOGETHER COMMUNITIES. 0 0 23744803 0 INFECTIOUS DISEASE DRUG REIMBURSEMENT PROGRAM (IDDAP): THE AGENCY ADMINISTERS THE COMMONWEALTH OF MASSACHUSETTS' INFECTIOUS DISEASE DRUG ASSISTANCE PROGRAM PROVIDING LIFE-SAVING MEDICATIONS, PRESCRIPTION CO-PAYMENTS, AND HEALTH INSURANCE TO ELIGIBLE MASSACHUSETTS RESIDENTS WHO ARE OTHERWISE UNABLE TO OBTAIN THESE LIFESAVING DRUGS OR HEALTH INSURANCE. 1030106 5458 EDUCATION: THE AGENCY PROVIDES EDUCATION, SKILL-BUILDING AND CLINICAL MENTORING OPPORTUNITIES FOR HEALTH CARE PROVIDERS TO ADDRESS EFFECTIVE COUNSELING, DIAGNOSIS, TREATMENT AND CARE MANAGEMENT OF INDIVIDUALS LIVING WITH HIV/AIDS. 166957 179111 COMMUNITY BASED RESEARCH: THE AGENCY PROVIDES CLINICAL TRIAL PARTICIPANTS WITH THE OPPORTUNITY TO TEST NEW MEDICATIONS AND TREATMENT STRATEGIES WITH THE GOAL OF IDENTIFYING EASIER AND SAFER DRUG REGIMENS. THESE NEW REGIMENS HELP PATIENTS LIVE MORE PRODUCTIVE, COMFORTABLE AND HEALTHY LIVES. 24941866 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 34 0 1 51 1 0 0 0 0 0 0 0 0 0 0 0 0 X 8 7 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA X JULIE K MARSTON 6175021744 529 MAIN STREET SUITE 301 BOSTON MA 02129 X SCOTT SYLVIA PRESIDENT (UNTIL 9/23) 5.00 X X 0 0 0 MARK GIESE PRESIDENT (AS OF 10/23) 5.00 X X 0 0 0 PAUL MORENO VICE PRESIDENT 5.00 X X 0 0 0 KEVIN HERWIG TREASURER 5.00 X X 0 0 0 RORY SHEBLE-HALL CLERK 5.00 X X 0 0 0 ALFREDO HERNANDEZ-CHAVEZ DIRECTOR 5.00 X 0 0 0 ANN MARRESE DIRECTOR 5.00 X 87039 0 1080 MATTHEW MCGUIRK DIRECTOR 5.00 X 0 0 0 RHODA JOHNSON-TUCKETT DIRECTOR (UNTIL 4/24) 5.00 X 0 0 0 ROGER SANCHEZ DIRECTOR 5.00 X 0 0 0 JULIE K MARSTON EXECUTIVE DIRECTOR 40.00 X 191148 0 9763 RANDLE K KUTZEN DEP DIR OF OPS & IDDAP PRG 40.00 X 148034 0 23854 ANNE S HILLS SENIOR SOFTWARE DEVELOPER 40.00 X 161042 0 9960 DEBRA WINTERS CLINICAL DIRECTOR 40.00 X 129576 0 16423 716839 0 61080 4 0 1 0 GROUPWARE TECHNOLOGIES LLC 10437 INNOVATION DR WAUWATOSA WI 53226 SYSTEM CONSULTING & DESIGN 316278 INDIGO ASSOCIATES MANAGEMENT LLC 1261 WASHINGTON STREET GLOUCESTER MA 01930 FINANCIAL SERVICES 202232 2 25233189 122147 25355336 CLINICAL DRUG TRIAL TESTING 621500 179111 179111 CLASS FEES 541700 5458 5458 184569 25539905 184569 0 0 244228 140993 80867 22368 3065034 2895199 89375 80460 116006 106676 5768 3562 478044 446518 18081 13445 285436 262480 14193 8763 21081 17445 3636 267970 210970 57000 1037000 930236 105190 1574 8604 1614 6990 218282 147676 59679 10927 142487 139839 1637 1011 584297 577018 2688 4591 40657 40359 227 71 29329 29329 2962 2962 50866 49645 755 466 HEALTH INSURANCE - CHII 10278700 10278700 DRUG REIMBURSEMENT 8667169 8667169 FOOD 20144 117 20027 25558296 24941866 442175 174255 461082 377867 3308932 4348616 45539 41645 347217 315034 4854 32183 1620713 1186769 5441120 5987080 2188337 2722173 37325 40127 500000 1837060 1364773 4062722 4627073 X 1378398 1360007 1378398 1360007 5441120 5987080 -18391 0 X 0 1 X 1 1 1 X 24103321 24083245 24312962 24906452 25355336 122761316 24103321 24083245 24312962 24906452 25355336 122761316 122761316 122761316 622823 1.00000 1.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 19326 19326 0 322629 293347 29282 5262 2361 2901 32183 FINANCE LEASE LIABILITY 3843 OPERATING LEASE LIABILITY 1360930 1364773 X 25539905 0 25539905 0 25539905 25558296 0 25558296 0 25558296 PART X, LINE 2: GENERALLY, THE AGENCY'S INFORMATION RETURNS REMAIN OPEN FOR POSSIBLE EXAMINATION FOR THREE YEARS AFTER THE FILING DATE. WHILE NO INCOME TAX RETURNS ARE CURRENTLY BEING EXAMINED BY THE INTERNAL REVENUE SERVICE, TAX YEARS SINCE 2021 REMAIN OPEN. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY THE AGENCY AND HAS CONCLUDED THAT, AS OF JUNE 30, 2024, THERE ARE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY (OR ASSET) OR DISCLOSURE IN THE FINANCIAL STATEMENTS. X X X X 0 0 0 0 0 0 0 0 0 JULIE K MARSTON EXECUTIVE DIRECTOR 191148 0 0 0 0 0 0 0 9763 0 200911 0 0 0 RANDLE K KUTZEN DEP DIR OF OPS & IDDAP PRG 148034 0 0 0 0 0 0 0 23854 0 171888 0 0 0 ANNE S HILLS SENIOR SOFTWARE DEVELOPER 161042 0 0 0 0 0 0 0 9960 0 171002 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B IRS FORM 990 IS REVIEWED WITH THE DIRECTOR OF FINANCE. THE EXECUTIVE DIRECTOR AND THE TREASURER REVIEW WITH THE BOARD FINANCE COMMITTEE PRIOR TO APPROVAL AND SUBMISSION. A PDF COPY IS PROVIDED TO ALL BOARD MEMBERS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES ANNUAL DISCLOSURE OF CONFLICTS OR LACK OF CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION OF THE EXECUTIVE DIRECTOR IS REVIEWED AND APPROVED ANNUALLY BY THE BOARD OF DIRECTORS DURING THE BUDGET APPROVAL ACTIVITIES. THE EXECUTIVE DIRECTOR REVIEWS THE PERFORMANCE OF STAFF AND COMPARES SALARY LEVELS TO SIMILAR NON-PROFIT ORGANIZATIONS TO ENSURE COMPENSATION PARITY. FORM 990, PART VI, SECTION C, LINE 19 UPON WRITTEN REQUEST. FORM 990, PART VII, SECTION A: EMPLOYEE COMPENSATION THE ORGANIZATION'S FORMS W-2 ARE ISSUED BY GENESIS HR SOLUTIONS, LLC, A PROFESSIONAL EMPLOYER ORGANIZATION. FORM 990, PART VII, SECTION A: ANN MARRESE WAS AN EMPLOYEE UNTIL SEPTEMBER OF 2023, DURING WHICH TIME SHE WAS COMPENSATED $87,039. IN SEPTEMBER OF 2023 SHE BECAME A DIRECTOR. SHE WAS NOT COMPENSATED FOR HER ROLE AS A DIRECTOR.